Friday Feb 21
Geron: A Biotech Stock With Potential For Long-Term Gains
Geron Corporation may be a good investment on the basis of its patented drug candidate for myelofibrosis .
Geron: Where Did The Shares Go?
This is a question relating to Geron that was begging to be answered since November 7, 2013.
Geron: Billion-Dollar Drugs And Possibility Of Accelerated Approval
Geron was initially focused on stem cell development but that business eventually faded.
Geron Corporation Announces Closing of its Public Offering of Common...
Menlo Park, Calif. , February 4, 2014 - Geron Corporation announced today the closing of its previously announced public offering of 22,500,000 shares of its common stock, as well as 3,375,000 additional shares of its common stock pursuant to the full exercise of the underwriters' option to purchase additional shares.
Notable Runners - Provectus Pharmaceuticals, Inc. (OTCMKTS:PVCT),...
Jet Life Penny Stocks is engaged in providing the most up to date and useful information on the Best Penny Stocks that are poised to breakout.